Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      WebMD Announces Third Quarter Financial Results

      WebMD Total Revenue Increased 21%; Advertising Revenue Increased 26%

      WebMD Adjusted EBITDA Increased 46%


      News provided by

      WebMD

      Nov 03, 2010, 04:00 ET

      Share this article

      Share this article


      NEW YORK, Nov. 3, 2010 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, today announced financial results for its third quarter ended September 30, 2010:

      • Revenue was $135.3 million, compared to $111.6 million in the prior year period, an increase of 21%.
      • Earnings before interest, taxes, non-cash and other items ("Adjusted EBITDA") was $44.6 million, compared to $30.6 million in the prior year period, an increase of 46%.
      • Income from continuing operations was $14.6 million or $0.24 per share, compared to $2.9 million or $0.05 per share in the prior year period.
      • Net income was $13.6 million or $0.22 per share, compared to $30.3 million or $0.61 per share in the prior year period. Net income would have been $16.0 million in the current period as compared to $5.0 million in the prior year period without the effect of the after-tax impact of a loss on convertible notes of $(1.4) million and a loss from discontinued operations of $(1.0) million in the current period and the after-tax impact of income from discontinued operations of $27.5 million and a loss attributable to non-controlling interest of $(2.2) million in the prior year period.

      "Our strong financial and operating performance underscores WebMD's continued momentum in providing the most valuable brand of health and wellness information to the marketplace today," said Wayne Gattinella, President and CEO. "The scale and engagement of the WebMD consumer and physician audiences are drawing more dollars from traditional marketing channels as the transformation to digital marketing in the health sector takes hold."

      Financial Summary

      Revenue for the third quarter was $135.3 million, compared to $111.6 million in the prior year period, an increase of 21%.

      Public portal advertising and sponsorship revenue was $113.1 million for the third quarter, compared to $89.4 million in the prior year period, an increase of 26%. Traffic to the WebMD Health Network continued to grow, reaching an average of 83.3 million unique users per month and total traffic of 1.8 billion page views during the third quarter, increases of 41% and 23%, respectively, from a year ago. 1.5 million continuing medical education (CME) programs were completed on the WebMD Professional Network during the third quarter.

      Private portal services revenue was $22.2 million for the third quarter which was consistent with the prior year period. The base of large employers and health plans using WebMD's private Health and Benefits portals during the third quarter was 124.

      During the third quarter, WebMD repurchased $9.9 million principal amount of its 3 1/8% convertible notes and had conversions of $26.2 million principal amount of the notes, which resulted in the issuance of approximately 750 thousand shares of WebMD common stock.

      WebMD utilized $156 million in cash to complete a tender offer for 3 million shares of its common stock during the third quarter.

      As of September 30, 2010, WebMD had approximately $352 million in cash and cash equivalents and approximately $85 million in aggregate principal amount of its 3 1/8% convertible notes outstanding.

      Financial Guidance

      WebMD increased its financial guidance for 2010 today based on year-to-date actual results and its outlook for the fourth quarter.

      For the fourth quarter of 2010, WebMD expects:

      • Revenue to be in excess of $165 million, an increase of at least 20% over the prior year period. Advertising revenue is expected to increase at least 25% while private portal revenue is expected to decline by approximately 8%.
      • Adjusted EBITDA to be in excess of 40% of revenue.
      • Net income to be in excess of 16% of revenue.  

      For the year ended December 31, 2010, WebMD expects:  

      • Revenue to be in excess of $531 million, an increase of at least 21% over the prior year period. Advertising revenue is expected to increase at least 28% while private portal revenue is expected to decline by approximately 5%.
      • Adjusted EBITDA to be in excess of 32% of revenue.
      • Net income to be in excess of 8.3% of revenue.

      WebMD is providing a schedule (attached to this press release) to reflect these changes as well as updates for non-cash and other items primarily to reflect the impact of convertible note conversions and repurchases and the tender offer completed by WebMD during the third quarter of 2010.

      Analyst and Investor Conference Call

      As previously announced, WebMD will hold a conference call with investors and analysts to discuss its third quarter results at 4:45 p.m. (Eastern) today. The call can be accessed at www.wbmd.com (in the Investor Relations section). A replay of the audio webcast will be available at the same web address.

      About WebMD

      WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications.

      The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList, theHeart.org and drugs.com.

      All statements contained in this press release and the related analyst and investor conference call, other than statements of historical fact, are forward-looking statements, including those regarding:   guidance on our future financial results and other projections or measures of our future performance; market opportunities and our ability to capitalize on them; and the benefits expected from new or updated products or services and from other potential sources of additional revenue. These statements speak only as of the date of this press release, are based on our current plans and expectations, and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements.  These risks and uncertainties include those relating to:  market acceptance of our products and services; our relationships with customers and strategic partners; and changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology industries.  Further information about these matters can be found in our Securities and Exchange Commission filings. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

      This press release, and the accompanying tables, include both financial measures in accordance with accounting principles generally accepted in the United States of America, or GAAP, as well as certain non-GAAP financial measures.  The tables attached to this press release include reconciliations of these non-GAAP financial measures to GAAP financial measures. In addition, an "Explanation of Non-GAAP Financial Measures" is attached to this press release as Annex A.  

      WebMD®, Medscape®, eMedicine®, MedicineNet®, RxList®, Subimo®, Medsite®, Summex® and Medscape® Mobile are trademarks of WebMD Health Corp. or its subsidiaries.

      WEBMD HEALTH CORP.

      CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands, except per share data, unaudited)






      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2010


      2009


      2010


      2009









      Revenue

      $ 135,305


      $ 111,568


      $ 366,042


      $ 300,463

      Cost of operations

      47,610


      41,965


      135,972


      117,759

      Sales and marketing

      28,957


      26,265


      86,789


      80,623

      General and administrative

      22,964


      21,967


      62,350


      65,818

      Depreciation and amortization

      6,935


      7,134


      20,268


      21,193

      Interest income

      21


      1,840


      3,850


      6,060

      Interest expense

      1,797


      5,541


      10,106


      17,858

      (Loss) gain on convertible notes

      (2,232)


      -


      (16,970)


      10,120

      Loss on investments

      131


      -


      22,977


      -

      Other income (expense), net

      107


      (123)


      (92)


      (944)

      Income from continuing operations before income tax provision (benefit)

      24,807


      10,413


      14,368


      12,448


      Income tax provision (benefit)

      10,193


      5,389


      (4,140)


      4,922

      Consolidated income from continuing operations

      14,614


      5,024


      18,508


      7,526


      Consolidated (loss) income from discontinued operations, net of tax

      (1,024)


      27,462


      (1,024)


      14,695

      Consolidated net income inclusive of noncontrolling interest

      13,590


      32,486


      17,484


      22,221


      Income attributable to noncontrolling interest

      -


      (2,184)


      -


      (3,181)

      Net income attributable to Company stockholders

      $   13,590


      $   30,302


      $   17,484


      $   19,040










      Amounts attributable to Company stockholders:









      Income from continuing operations

      $   14,614


      $     2,872


      $   18,508


      $     3,381


      (Loss) income from discontinued operations

      (1,024)


      27,430


      (1,024)


      15,659

      Net income attributable to Company stockholders

      $   13,590


      $   30,302


      $   17,484


      $   19,040










      Basic income (loss) per common share:









      Income from continuing operations

      $       0.25


      $       0.06


      $       0.33


      $       0.07


      (Loss) income from discontinued operations

      (0.02)


      0.59


      (0.01)


      0.34

      Net income attributable to Company stockholders

      $       0.23


      $       0.65


      $       0.32


      $       0.41










      Diluted income (loss) per common share:









      Income from continuing operations

      $       0.24


      $       0.05


      $       0.31


      $       0.06


      (Loss) income from discontinued operations

      (0.02)


      0.56


      (0.02)


      0.33

      Net income attributable to Company stockholders

      $       0.22


      $       0.61


      $       0.29


      $       0.39










      Weighted-average shares outstanding used in computing  income (loss) per common share:








           Basic

      58,095


      46,096


      54,602


      45,637

           Diluted

      61,435


      48,609


      58,660


      47,167



      WEBMD HEALTH CORP.

      CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION

      (In thousands, unaudited)










      Three Months Ended


      Nine Months Ended




      September 30,


      September 30,




      2010


      2009


      2010


      2009

      Revenue










      Public portal advertising and sponsorship


      $ 113,078


      $   89,414


      $ 299,927


      $ 232,695


      Private portal services


      22,227


      22,154


      66,115


      67,768




      $ 135,305


      $ 111,568


      $ 366,042


      $ 300,463











      Earnings before interest, taxes, non-cash and other items ("Adjusted EBITDA") (a)


      $   44,578


      $   30,564


      $ 104,536


      $   65,846











      Interest, taxes, non-cash and other items  (b)










      Interest income


      21


      1,840


      3,850


      6,060


      Interest expense


      (1,797)


      (5,541)


      (10,106)


      (17,858)


      Income tax (provision) benefit


      (10,193)


      (5,389)


      4,140


      (4,922)


      Depreciation and amortization


      (6,935)


      (7,134)


      (20,268)


      (21,193)


      Non-cash stock-based compensation


      (8,804)


      (9,217)


      (23,605)


      (27,783)


      Non-cash advertising


      -


      -


      -


      (1,753)


      (Loss) gain on convertible notes


      (2,232)


      -


      (16,970)


      10,120


      Loss on investments


      (131)


      -


      (22,977)


      -


      Other income (expense), net


      107


      (99)


      (92)


      (991)

      Consolidated income from continuing operations


      14,614


      5,024


      18,508


      7,526


      Consolidated (loss) income from discontinued operations, net of tax


      (1,024)


      27,462


      (1,024)


      14,695

      Consolidated net income inclusive of noncontrolling interest


      13,590


      32,486


      17,484


      22,221


      Income attributable to noncontrolling interest


      -


      (2,184)


      -


      (3,181)

      Net income attributable to Company stockholders


      $   13,590


      $   30,302


      $   17,484


      $   19,040











      (a)

      See Annex A-Explanation of Non-GAAP Financial Measures.

      (b)

      Reconciliation of Adjusted EBITDA to consolidated income from continuing operations.



      WEBMD HEALTH CORP.

      CONDENSED CONSOLIDATED BALANCE SHEETS

      (In thousands, unaudited)
















      September 30, 2010


      December 31, 2009

      Assets





      Cash and cash equivalents


      $                   352,199


      $               459,766

      Accounts receivable, net


      120,361


      118,155

      Prepaid expenses and other current assets


      17,055


      11,419

      Investments


      -


      9,932

      Deferred tax assets


      27,346


      -

             Total current assets


      516,961


      599,272







      Investments


      -


      338,446

      Property and equipment,  net


      62,221


      52,194

      Goodwill


      202,104


      202,104

      Intangible assets, net


      23,388


      26,020

      Deferred tax assets


      78,631


      50,789

      Other assets


      17,407


      19,723

      Total Assets


      $                   900,712


      $            1,288,548







      Liabilities and Equity





      Accrued expenses


      $                     63,832


      $                 63,721

      Deferred revenue


      101,887


      98,474

      1.75% convertible notes


      -


      264,583

      Deferred tax liabilities


      -


      12,955

      Liabilities of discontinued operations


      20,574


      34,197

           Total current liabilities


      186,293


      473,930







      3 1/8% convertible notes, net of discount of $5,693 at September 30, 2010 and $22,641 at December 31, 2009


      79,634


      227,659

      Other long-term liabilities


      24,263


      22,191







      Stockholders' equity


      610,522


      564,768







      Total Liabilities and Equity


      $                   900,712


      $            1,288,548



      WEBMD HEALTH CORP.

      CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands, unaudited)























      Nine Months Ended







      September 30,







      2010


      2009

      Cash flows from operating activities:






      Consolidated net income inclusive of noncontrolling interest


      $        17,484


      $        22,221


      Adjustments to reconcile consolidated net income inclusive of noncontrolling interest to net cash provided by operating activities:







      Consolidated loss (income) from discontinued operations, net of tax


      1,024


      (14,695)



      Depreciation and amortization


      20,268


      21,193



      Non-cash interest, net


      4,862


      7,737



      Non-cash advertising


      -


      1,753



      Non-cash stock-based compensation


      23,605


      27,783



      Deferred income taxes


      (17,260)


      7,563



      Loss (gain) on convertible notes


      16,970


      (10,120)



      Loss on investments


      22,977


      -



      Changes in operating assets and liabilities:








      Accounts receivable


      (2,206)


      6,010




      Prepaid expenses and other, net


      (3,006)


      (8,394)




      Accrued expenses and other long-term liabilities


      1,695


      (7,740)




      Deferred revenue


      3,413


      4,248





      Net cash provided by continuing operations


      89,826


      57,559





      Net cash (used in) provided by discontinued operations


      (17,082)


      9,273





      Net cash provided by operating activities


      72,744


      66,832










      Cash flows from investing activities:






      Proceeds from sales of available-for-sale securities


      362,259


      2,200


      Purchases of property and equipment


      (20,329)


      (14,248)


      Finalization of sale price of discontinued operations


      (1,430)


      2,840





      Net cash provided by (used in) continuing operations


      340,500


      (9,208)





      Net cash used in discontinued operations


      -


      (3,315)





      Net cash provided by (used in) investing activities


      340,500


      (12,523)










      Cash flows from financing activities:






      Proceeds from exercise of stock options


      57,168


      30,004


      Cash used for withholding taxes due on stock-based awards


      (76,559)


      (1,234)


      Repurchases of convertible notes


      (94,475)


      (123,857)


      Purchase of treasury stock under repurchase program


      (14,914)


      -


      Payment for shares tendered in 2009, delivered in 2010


      (6,818)


      -


      Purchase of treasury stock in tender offers


      (399,216)


      -


      Excess tax benefit on stock-based awards


      14,003


      63





      Net cash used in financing activities


      (520,811)


      (95,024)

      Effect of exchange rates on cash


      -


      420

      Net decrease in cash and cash equivalents


      (107,567)


      (40,295)

      Cash and cash equivalents at beginning of period


      459,766


      629,848

      Cash and cash equivalents at end of period


      $      352,199


      $      589,553



      WEBMD HEALTH CORP.

      CONSOLIDATED NET INCOME ATTRIBUTABLE TO COMPANY STOCKHOLDERS

      (In thousands, except per share data, unaudited)





      Three Months Ended


      Nine Months Ended




      September 30,


      September 30,




      2010


      2009


      2010


      2009











      Numerator:









      Income from continuing operations


      $14,614


      $  2,872


      $18,508


      $  3,381


      Effect of participating non-vested restricted stock


      (152)


      (31)


      (222)


      (37)

      Income from continuing operations - Basic


      14,462


      2,841


      18,286


      3,344


      Effect of dilutive securities of subsidiary


      -


      (188)


      -


      (285)

      Income from continuing operations - Diluted


      $14,462


      $  2,653


      $18,286


      $  3,059











      (Loss) income from discontinued operations


      $ (1,024)


      $27,430


      $ (1,024)


      $15,659


      Effect of participating non-vested restricted stock


      12


      (293)


      12


      (171)

      (Loss) income from discontinued operations --Basic


      (1,012)


      27,137


      (1,012)


      15,488


      Effect of dilutive securities of subsidiary


      -


      (3)


      -


      53

      (Loss) income from discontinued operations --Diluted


      $ (1,012)


      $27,134


      $ (1,012)


      $15,541











      Denominator:









      Weighted-average shares — Basic


      58,095


      46,096


      54,602


      45,637


      Employee stock options and restricted stock


      3,340


      2,513


      4,058


      1,530

      Adjusted weighted-average shares after assumed conversions - Diluted


      61,435


      48,609


      58,660


      47,167











      Basic income (loss) per common share:










      Income from continuing operations


      $    0.25


      $    0.06


      $    0.33


      $    0.07


      (Loss) income from discontinued operations


      (0.02)


      0.59


      (0.01)


      0.34

      Net income attributable to Company stockholders


      $    0.23


      $    0.65


      $    0.32


      $    0.41











      Diluted income (loss) per common share:










      Income from continuing operations


      $    0.24


      $    0.05


      $    0.31


      $    0.06


      (Loss) income from discontinued operations


      (0.02)


      0.56


      (0.02)


      0.33

      Net income attributable to Company stockholders


      $    0.22


      $    0.61


      $    0.29


      $    0.39



      WebMD Health Corp.

      2010 Financial Guidance

      (in millions)





















      Quarter Ended


      Year Ended



      December 31, 2010


      December 31, 2010



      $


      As % of
      Revenue


      $


      As % of
      Revenue










      Revenue - in excess of


      $ 165.0


      100%


      $ 531.0


      100%










      Earnings before interest, taxes, non-cash









       and other items ("Adjusted EBITDA") - in excess of




      40%




      32%










      Interest, taxes, non-cash and other items (a)









      Interest expense, net




      -1.0%




      -1.5%

      Depreciation and amortization




      -5.0%




      -5.4%

      Non-cash stock-based compensation




      -6.0%




      -6.3%

      Loss on convertible notes (b)




      0.0%




      -3.2%

      Loss on investments (b)




      0.0%




      -4.3%

      Other expenses, net (b)




      0.0%




      0.0%

      Consolidated pre-tax income from continuing operations - in excess of




      28.0%




      11.3%










      Income tax provision




      -12.0%




      -3.0%










      Consolidated income from continuing operations - in excess of




      16.0%




      8.3%



















      (a)  Reconciliation of Adjusted EBITDA to consolidated income from continuing operations; See Annex A - Explanation of Non-GAAP Financial Measures.


      (b)  The above table reflects actual amounts through September 30, 2010 for “loss on convertible notes,” “loss on investments” and “other expenses, net” but does not reflect guidance for these items for the quarter ending December 31, 2010 in either column. We do not make projections for these items, although they may recur in future quarters.


      Additional information regarding fourth quarter and full year 2010 forecast:

      • Income tax rate is forecasted to be approximately 42% of pretax income for the fourth quarter of 2010.  
      • The distribution of the revenue is expected to be approximately 87% public portal advertising and sponsorship and 13% private portal services for the fourth quarter of 2010.
      • Weighted- average basic and diluted shares outstanding for the fourth quarter of 2010 is expected to be approximately 57 million and 63 million, respectively.  The weighted-average diluted shares outstanding for the fourth quarter of 2010 includes approximately 2.4 million shares related to outstanding 3 1/8 % Notes as these Notes are expected to be dilutive to earnings per share for the fourth quarter.
      • Weighted-average basic and diluted shares outstanding for full year 2010 is expected to be approximately 55 million and 63 million, respectively.  The weighted-average diluted shares outstanding for the full year 2010 does not include any shares related to outstanding 3 1/8 % Notes as these Notes are not expected to be dilutive to earnings per share for the full year 2010.


      ANNEX A

      Explanation of Non-GAAP Financial Measures

      (All dollar amounts in thousands)

      The accompanying WebMD Health Corp. press release and financial tables include both financial measures in accordance with U.S. generally accepted accounting principles, or GAAP, as well as non-GAAP financial measures.  The non-GAAP financial measures represent earnings before interest, taxes, non-cash and other items (which we refer to as "Adjusted EBITDA") and related per share amounts.  Adjusted EBITDA should be viewed as supplemental to, and not as an alternative for, "consolidated income (loss) from continuing operations" or "net income (loss) attributable to Company stockholders" calculated in accordance with GAAP.  The accompanying financial tables include reconciliations of non-GAAP financial measures to GAAP financial measures.  

      Adjusted EBITDA is used by our management as an additional measure of our company's performance for purposes of business decision-making, including developing budgets, managing expenditures, and evaluating potential acquisitions or divestitures.  Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our company's financial results that may not be shown solely by period-to-period comparisons of consolidated income (loss) from continuing operations or net income (loss) attributable to Company stockholders.  In addition, we use Adjusted EBITDA in the incentive compensation programs applicable to many of our employees in order to evaluate our company's performance.  Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature.  In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in consolidated income (loss) from continuing operations or net income (loss) attributable to Company stockholders, as well as trends in those items.  The amounts of those items are set forth, for the applicable periods, in the reconciliations of Adjusted EBITDA to consolidated income (loss) from continuing operations or to net income (loss) attributable to Company stockholders that accompany our press releases and disclosure documents containing non-GAAP financial measures, including the reconciliations contained in the accompanying financial tables.

      We believe that the presentation of Adjusted EBITDA is useful to investors in their analysis of our results for reasons similar to the reasons why our management finds it useful and because it helps facilitate investor understanding of decisions made by management in light of the performance metrics used in making those decisions.  In addition, as more fully described below, we believe that providing Adjusted EBITDA, together with a reconciliation of Adjusted EBITDA to consolidated income (loss) from continuing operations or to net income (loss) attributable to Company stockholders, helps investors make comparisons between our company and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation.  However, Adjusted EBITDA is intended to provide a supplemental way of comparing our company with other public companies and is not intended as a substitute for comparisons based on "consolidated income (loss) from continuing operations" or "net income (loss) attributable to Company stockholders" calculated in accordance with GAAP.  In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance.  Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable SEC rules.

      The following is an explanation of the items excluded by us from Adjusted EBITDA but included in consolidated income (loss) from continuing operations:

      • Depreciation and Amortization.  Depreciation and amortization expense is a non-cash expense relating to capital expenditures and intangible assets arising from acquisitions that are expensed on a straight-line basis over the estimated useful life of the related assets.  We exclude depreciation and amortization expense from Adjusted EBITDA because we believe that (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired tangible and intangible assets.  Accordingly, we believe that this exclusion assists management and investors in making period-to-period comparisons of operating performance.  Investors should note that the use of tangible and intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation and should also note that such expense will recur in future periods.

      • Stock-Based Compensation Expense.  Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards to employees.  We believe that excluding the effect of stock-based compensation from Adjusted EBITDA assists management and investors in making period-to-period comparisons in its operating performance because (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of the timing of grants of new stock-based awards, including grants in connection with acquisitions.  Additionally, we believe that excluding stock-based compensation from Adjusted EBITDA assists management and investors in making meaningful comparisons between our operating performance and the operating performance of other companies that may use different forms of employee compensation or different valuation methodologies for their stock-based compensation.  Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods.  Investors should also note that such expenses will recur in the future.  Stock-based compensation expenses included in the Consolidated Statement of Operations are summarized as follows:


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2010

      2009


      2010

      2009







      Non-cash stock-based compensation included in:







      Cost of operations

      $    1,889

      $   1,743


      $    5,153

      $    4,921


      Sales and marketing

      $    1,867

      $   1,948


      $    5,749

      $    5,499


      General and administrative

      $    5,048

      $   5,526


      $  12,703

      $  17,363


      Income (loss) from discontinued operations

      $          --

      $      112


      $          --

      $       654



      • Non-Cash Advertising Expense.  This expense relates to the usage of non-cash advertising obtained from News Corporation ("Newscorp") in exchange for equity securities issued in 2000.  The advertising was available only on various Newscorp properties, primarily its television network and cable channels, without any cash cost to us and expired in 2009.  We exclude this expense from Adjusted EBITDA (i) because it is a non-cash expense, (ii) because it is incremental to other non-television cash advertising expense that we may otherwise incur and (iii) to assist management and investors in comparing its operating results over multiple periods.  Investors should note that it is likely that we derived some benefit from such advertising. Non-cash advertising expenses included in the Consolidated Statement of Operations in Sales and Marketing expense were $1,753 for the nine months ended September 30, 2009.  

      • Interest Income and Expense.  Interest income is associated with the level of marketable debt securities and other interest bearing accounts in which we invest, as well as with interest expense arising from our company's capital structure (including non-cash interest expense relating to our convertible notes).  Interest income and expense varies over time due to a variety of financing transactions and due to acquisitions and divestitures that we have entered into or may enter into in the future.  We have, in the past, issued convertible debentures, repurchased shares in cash tender offers and repurchased shares and convertible debentures through other repurchase transactions, and completed the divestiture of certain businesses.  We exclude interest income and interest expense from Adjusted EBITDA (i) because these items are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different capital structures.  Investors should note that interest income and expense will recur in future periods.  The following provides detail of the components of interest expense of our convertible notes:


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2010

      2009


      2010

      2009








      Non-cash interest expense







      1.75% Convertible Notes

      $          --

      $      303


      $       885

      $     970


      3 1/8% Convertible Notes

      $       977

      $   2,124


      $    4,264

      $  6,767

      Cash interest expense







      1.75% Convertible Notes

      $          --

      $   1,157


      $    1,564

      $  3,760


      3 1/8% Convertible Notes

      $       820

      $   1,955


      $    3,392

      $  6,354



      • Income Tax Provision (Benefit).  We maintain a valuation allowance on a portion of our net deferred tax assets (including our net operating loss carryforwards), the amount of which may change from quarter to quarter based on factors that are not directly related to our results for the quarter.  The valuation allowance is either reversed through the statement of operations or additional paid-in capital.  The timing of such reversals has not been consistent and as a result, our income tax expense can fluctuate significantly from period to period in a manner not directly related to our operating performance.  We exclude the income tax provision (benefit) from Adjusted EBITDA (i) because we believe that the income tax provision (benefit) is not directly attributable to the underlying performance of our business operations and, accordingly, its exclusion assists management and investors in making period-to-period comparisons of operating performance and (ii) to assist management and investors in making comparisons to companies with different tax attributes.  Investors should note that income tax provision (benefit) will recur in future periods.

      • Other Items.  We engage in other activities and transactions that can impact our overall consolidated income (loss) from continuing operations.  In recent periods, these other items have included, but were not limited to, (i) legal expenses relating to the ongoing Department of Justice investigation, (ii) gain or loss on repurchases and conversions of our convertible notes, (iii) a reduction of certain sales and use tax contingencies resulting from the expiration of certain applicable statutes of limitations, (iv) advisory expenses relating to the merger of HLTH Corporation into our company in 2009, (v) gain or loss on investments, and (vi) restructuring charge.  We exclude these other items from Adjusted EBITDA because we believe these activities or transactions are not directly attributable to the performance of our business operations and, accordingly, their exclusion assists management and investors in making period-to-period comparisons of operating performance.  Investors should note that some of these other items may recur in future periods.

      SOURCE WebMD

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.